Скачать или смотреть The investor wants to meet us again – what now?

The life science sector is key to finding models for sustainable growth, and will continue to grow in importance in Norway for the foreseeable future. Life science covers the health, marine, agriculture and industrial sectors. How can your life science business attract private investors?

We pick up where we left off last year. What comes after the initial investor meeting? What is the investor outlook for 2021?

Preparing for investor meetings is central for every life science company. But what happens after the investor is interested, and starts a formal process to analyze your business case? When should you start preparing for it?

Speakers

10.00: Hanne Mette D. Kristensen, CEO, The Life Science Cluster - Welcome

10.15: Øivind Enger, Partner & Investment Advisor, Sarsia Seed - Introduction

10.30: Maren Hjorth Bauer, Managing Partner and Founder, Fynd Ocean Ventures

10.45: Jonas Hallén, Chief Medical Officer, Co-Founder, Arxx Therapeutics

11.00: Ingrid Teigland Akay, Managing Partner, Hadean Ventures

11.15: Birgitte Gangmark Villmo, Senior Associate, Investinor

11.30: Break

11.45: Nils Rynning Mork, Admincontrol

12.00: Tord Fondevik, partner, head of dept M&A, Schjødt

12.15: Aase Gundersen, Special Counsel, SANDS

12.30: Jonathan Gertler, Co-Founder, Managing Partner & CEO, Back Bay Life Science Advisors